Focus Stocks
Approaching Resistance - Las Vegas Sands
Published on Wednesday, 08 February 2012 07:16 Written by TradersHuddle Wire
New York, February 8th (TradersHuddle.com) - Shares of Las Vegas Sands Corp. (NYSE:LVS) are trading very close to calculated resistance at $52.35 with the current price action closing at just $51.06 placing the stock near levels that make it difficult to buy.
Las Vegas Sands Corp. (NYSE:LVS) owns and operates casino resorts and convention centers. The Company operates in United States, Macau, and Singapore and offers a wide range of gaming activities and entertainment as well as overnight accommodations in properties like the Venetian and the Palazzo in Las Vegas, NV. Its expo centers host a wide range of entertainment shows, expositions, and other activities.
Las Vegas Sands' current stock range is defined by current calculated support defined at $41.77 and by the resistance level at $52.35, the stock is clearly over-extended from support, making it difficult to establishing new long positions at this level.
Traders don't have a clear entry point for Las Vegas Sands, as the stock is well above support, however, as the stock pulls back towards $41.77 it will definitely provide a reference point to establish a trade. On the other hand if the stock decides to break above resistance level at $52.35 then traders will get an opportunity to enter Las Vegas Sands stock by establishing a position as the stock moves to a higher range.
Related Articles
- Las Vegas Sands Broke Support
- Will Las Vegas Sands recover?
- Is Las Vegas Sands Closing in to Support?
- Stock Futures Lower Ahead of ADP. Stocks to Watch: AAPL, BAC, BRCM, CHRS, CHK, CMCSA, CVS, LVS, TRIP, WYNN
- Trading Idea: Is Las Vegas Sands Breaking Down?
- New Ratings: WYNN, LVS, TSO, VLO
- Las Vegas Sands is Near a Key Support Area
- Stocks Gained; The Dow Logged Third Straight Win
- Las Vegas Sands Is Close to the 50 Day Moving Average
- Las Vegas Sands Is Approaching its 50 Day Moving Average
Related Partner Headlines
- Las Vegas Sands Corp (LVS): Today's Featured Services Loser - TheStreet.com
- Las Vegas Sands Corp (LVS): Today's Featured Services Loser - TheStreet.com
- Las Vegas Sands Corp (LVS): Today's Featured Leisure Winner - TheStreet.com
- Las Vegas Sands Corp (LVS): Today's Featured Leisure Loser - TheStreet.com
- UPDATE: Citi Lowers Las Vegas Sands' PT - Benzinga
- Las Vegas Sands Corp (LVS): Today's Featured Leisure Winner - TheStreet.com
- Las Vegas Sands Beats Wall Street Estimates - Benzinga
- Las Vegas Sands Stock Hits New 52-Week High (LVS) - TheStreet.com
- Las Vegas Sands Stock Hits New 52-Week High (LVS) - TheStreet.com
- Las Vegas Sands Stock To Go Ex-dividend Tomorrow (LVS) - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Toyota Is Back as May Sales Continue Auto Industry Recovery - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









